Get Started in Minutes
How Votrient Copay Assistance Works
1 – Check Your Coverage/Benefits Verification
Our team of expert billers finds the best avenues of coverage that minimize out-of-pocket costs.
2 – Transfer Prescription to AmeriPharma
We process your prescription by working with your previous pharmacy or prescriber, making the transition quick and easy.
3 – Prior Authorization
Our team of specialists obtains approval from your insurance companies within 24 to 72 hours.
4 – Copay Assistance & Financial Aid
We secure financial aid and decrease copays, out-of-pocket expenses, and high deductibles. To date, AmeriPharma Specialty Care has secured $55 million in financial assistance for our patients.
5 – Nursing Care Coordination
AmeriPharma puts your schedule and home environment first when scheduling and coordinating one of our specialized nurses for your in-home infusions.
6 – Delivery Coordination
Medications are always delivered in strict compliance with the specific requirements for immune globulin shipping. Next-day and overnight cold-chain deliveries are coordinated around your schedule.
What Is Votrient?
Votrient (pazopanib) is a targeted therapy medication used for the treatment of renal cell carcinoma and soft tissue sarcoma. Targeted therapy medications are designed to only attack cancer cells while causing less harm to normal cells.
Votrient belongs to the drug class called tyrosine kinase inhibitors. More specifically, it is an inhibitor of vascular endothelial growth factor (VEGFR) which works by blocking the enzyme tyrosine kinase to stop unnecessary cell growth and division. Patients should be monitored for liver function before the initiation of therapy and throughout therapy due to the increased risk of severe hepatic toxicity. Use of targeted therapy has been increasing over the years as it increases survival rates and improves quality of life.
What is Votrient Used For?
Votrient is an FDA-approved targeted therapy medication for the treatment of advanced kidney cancer and advanced soft tissue sarcoma. It is given to patients who have been receiving chemotherapy. Votrient is available in a tablet formulation, and it should be taken on an empty stomach (at least one hour before or two hours after eating).
Renal cell carcinoma is a common type of tumor in the kidney. Treatment usually includes radiation and chemotherapy before the removal of the tumor. Soft tissue sarcoma is a type of cancer that originates in fat, muscle, or blood vessels throughout the body. Votrient is used as targeted therapy to destroy tumors before surgical removal is needed.
Copay and Financial Assistance
AmeriPharma Specialty Care alleviates financial burdens for patients and their families
Advanced software locates funding sources to match you with top-dollar foundation programs
One of our copay assistance specialists will assist with the application process
Automatic updates will be sent to you and your physician on the status of the funding
Votrient Side Effects
Common side effects include:
- Upset stomach
- Loss of appetite
- Hair loss
- Bone or muscle pain
- Mouth pain or irritation
- Change in taste
Serious side effects include:
- Liver damage
- Thyroid issues
- Sudden swelling or numbness in the arm or leg
- Irritation of palms of hands or soles of feet
- Black or tarry stools
Directions for Use
Votrient is available in 200 mg and 400 mg tablets.
- 200 mg tablets are gray, with a modified capsule shape, and film coated with “GS JT” printed on one side.
- 400 mg tablets are yellow, with a modified capsule shape, and film coated with “GS UHL” printed on one side.
The initial recommended dose is 800 mg by mouth once daily without food. Votrient should be taken 1 hour before or 2 hours after meals. The dose should not exceed 800 mg per day. Doses should be reduced in patients with hepatic impairment.
Votrient tablets should be stored at room temperature, away from moisture.
Since Votrient is metabolized by the liver, grapefruit and grapefruit juice should be avoided during therapy. Patients should avoid receiving live vaccines during treatment and for at least a year after treatment.
Votrient should not be used in pregnant or lactating patients. Safety and efficacy has not been studied in patients younger than 18 years of age.
Votrient should not be crushed, broken, or chewed.
Monitoring patients closely during therapy is crucial to provide the best care and therapy for patients. Patients should inform their healthcare providers of any sudden change or onset of symptoms while using Votrient.